99 results
8-K
EX-99.2
MDXG
Mimedx Group Inc
30 Apr 24
MIMEDX Announces First Quarter 2024 Operating and Financial
4:10pm
particulate products are on the market and classified either as Section 361 products or with FDA 510(k) clearance In March following RFD outcome, we filed
DEFC14A
acaafm1ux
3 May 21
Proxy in contested solicitation
9:36am
DEFC14A
aym2aedng
30 Apr 21
Proxy in contested solicitation
5:02pm
PRRN14A
blv1ucxjibu j34
26 Apr 21
Revised preliminary proxy statement filed by non-management
3:58pm
PREC14A
ryj71wxotnfbk
20 Apr 21
Preliminary proxy with contested solicitation
5:47pm
PREC14A
gsgc8a4qdm4zgzem
20 Apr 21
Preliminary proxy with contested solicitation
8:14am